We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Deep Learning Model Helps Drug Developers Target SARS-CoV-2's Main Protease

News   Oct 29, 2020 | Original story from Michigan State University

 
Deep Learning Model Helps Drug Developers Target SARS-CoV-2's Main Protease

Credit: Daniel Roberts/ Pixabay

 
 
Advertisement
 

RELATED ARTICLES

None of the SARS-CoV-2 Mutations Currently Documented Appear To Increase Its Transmissibility

News

Researchers have so far identified 12,706 mutations in SARS-CoV-2. For 398 of the mutations, there is strong evidence that they have occurred repeatedly and independently.

READ MORE

Model Designed To Predict Cellular Drug Targets Against COVID-19

News

A computational model of a human lung cell has been used to understand how SARS-CoV-2 draws on human host cell metabolism to reproduce.

READ MORE

Environmental Alert System Could Cut Cold Weather-Related Deaths

News

A team of scientists has recently developed a cold-health watch and warning system for cold waves.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Informatics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE